<DOC>
	<DOCNO>NCT00765375</DOCNO>
	<brief_summary>• To determine safety efficacy Botox Treatment subject mild moderate acne vulgaris define Investigator 's Global Assessment ( IGA )</brief_summary>
	<brief_title>Safety Efficacy Use Botox Acne</brief_title>
	<detailed_description>• 90 day trial , botox inject baseline/screening visit . Photos take throughout study patient evaluate masked injector evaluator mask evaluator . Patient complete subject evaluation visit . Follow-up visit occur Day 3 , 7 , 14 , 30 90 .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Between age 18 50 year age Not pregnant negative pregnancy test , plan get pregnant Mild moderate bilateral acne lesion face Able understand requirement study sign Informed Consent Form Have time ability complete study comply instruction ( i.e around duration study ) Skin type I , II , III , IV V Subject skin type VI Subject significant concurrent illness , diabetes , epilepsy , lupus congestive heart disease Concurrent skin condition affect area treat Prior exposure serotype botulinum toxin purpose 3 month immediately prior study enrollment Prior surgery area treat within 3 month initial treatment clinical evaluation Open laceration , abrasion active cold sore herpes sore , multiple dysplastic nevus area treat ? Permanent semipermanent dermal filler treatment within last 6 month Medium deep depth chemical peel resurface procedure within 3 month treatment clinical evaluation Has use oral isotretinoin ( Accutane ) within 6 month , use topical isotretinoin within 3 month , initial treatment clinical evaluation Prior light /laser treatment target location within 3 month enrollment course clinical evaluation Any physical mental condition , investigator 's opinion would make unsafe subject participate clinical evaluation Use oral antibiotic acne and/or medication cause photosensitivity within 2 week initial treatment Participation study another investigational device drug within 3 month enrollment Subject show symptom hormonal disorder Subject treat ( past present ) form treatment active cancer history skin cancer cancer area treat Subject currently use immunosuppressive medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>acne</keyword>
	<keyword>Botox</keyword>
	<keyword>cosmetic treatment</keyword>
</DOC>